Our animal data of CN133 treatment encouraged the combination of PD-1 blockade and HDAC inhibitor since PD-1 blockade can function by blocking the inhibitory interactions between tumor cells and CD8 + TILs [26]. The gene discussed is CD8A; the disease is neoplasm.